TVG Publications

Original Articles

2012

VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Values in Translation: How Asking the Right Questions Can Move Translational Science Toward Greater Health Impact
Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among post-menopausal women
Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs
Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS)
Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera

2011

Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival
Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells

Pages